Found: 27
Select item for more details and to access through your institution.
Antibody induced CD4 down-modulation of T cells is site-specifically mediated by CD64<sup>+</sup> cells.
- Published in:
- Scientific Reports, 2015, p. 18308, doi. 10.1038/srep18308
- By:
- Publication type:
- Article
Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36984-1
- By:
- Publication type:
- Article
Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11100-0
- By:
- Publication type:
- Article
Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines.
- Published in:
- Vaccines, 2022, v. 10, n. 3, p. 359, doi. 10.3390/vaccines10030359
- By:
- Publication type:
- Article
Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over time.
- Published in:
- Clinical & Translational Immunology, 2022, v. 11, n. 4, p. 1, doi. 10.1002/cti2.1388
- By:
- Publication type:
- Article
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection.
- Published in:
- PLoS ONE, 2022, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0262169
- By:
- Publication type:
- Article
An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses.
- Published in:
- PLoS ONE, 2021, v. 16, n. 9, p. 1, doi. 10.1371/journal.pone.0258041
- By:
- Publication type:
- Article
Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations.
- Published in:
- PLoS ONE, 2021, v. 16, n. 7, p. 1, doi. 10.1371/journal.pone.0253178
- By:
- Publication type:
- Article
Epitopes Displayed in a Cyclic Peptide Scaffold Bind SARS‐COV‐2 Antibodies.
- Published in:
- ChemBioChem, 2023, v. 24, n. 15, p. 1, doi. 10.1002/cbic.202300103
- By:
- Publication type:
- Article
An Adaptable Antibody‐Based Platform for Flexible Synthetic Peptide Delivery Built on Agonistic CD40 Antibodies.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 7, p. 1, doi. 10.1002/adtp.202200008
- By:
- Publication type:
- Article
Correction: Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
BCG‐induced cytokine release in bladder cancer cells is regulated by Ca<sup>2+</sup> signaling.
- Published in:
- Molecular Oncology, 2019, v. 13, n. 2, p. 202, doi. 10.1002/1878-0261.12397
- By:
- Publication type:
- Article
Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancer.
- Published in:
- European Journal of Immunology, 2017, v. 47, n. 2, p. 385, doi. 10.1002/eji.201646583
- By:
- Publication type:
- Article
Circulating specific antibodies enhance systemic cross-priming by delivery of complexed antigen to dendritic cells in vivo.
- Published in:
- European Journal of Immunology, 2012, v. 42, n. 3, p. 598, doi. 10.1002/eji.201141613
- By:
- Publication type:
- Article
Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-24347-7
- By:
- Publication type:
- Article
Infiltration of NK and plasma cells is associated with a distinct immune subset in non‐small cell lung cancer.
- Published in:
- Journal of Pathology, 2021, v. 255, n. 3, p. 243, doi. 10.1002/path.5772
- By:
- Publication type:
- Article
Antibodies from serum and CSF of multiple sclerosis patients bind to oligodendroglial and neuronal cell-lines.
- Published in:
- Brain Communications, 2023, v. 5, n. 3, p. 1, doi. 10.1093/braincomms/fcad164
- By:
- Publication type:
- Article
Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers.
- Published in:
- 2021
- By:
- Publication type:
- journal article
T-cell responses after haematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis.
- Published in:
- Immunology, 2013, v. 140, n. 2, p. 211, doi. 10.1111/imm.12129
- By:
- Publication type:
- Article
Both CD4.
- Published in:
- Immunology, 2011, v. 133, n. 3, p. 296, doi. 10.1111/j.1365-2567.2011.03439.x
- By:
- Publication type:
- Article
Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 1, doi. 10.1007/s00262-016-1909-3
- By:
- Publication type:
- Article
Plasma Proteomic Analysis in Non-Small Cell Lung Cancer Patients Treated with PD-1/PD-L1 Blockade.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3116, doi. 10.3390/cancers13133116
- By:
- Publication type:
- Article
Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 5, p. e2211497, doi. 10.1001/jamanetworkopen.2022.11497
- By:
- Publication type:
- Article
Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Telomerase as a Target for Therapeutic Cancer Vaccines and Considerations for Optimizing Their Clinical Potential.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.682492
- By:
- Publication type:
- Article
Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.615240
- By:
- Publication type:
- Article
Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article